Target intelligence / Profile preview

Staphylococcus epidermidis cell-surface receptor

Molecular classification
Receptor, Other
01

Overview

Staphylococcus epidermidis cell-surface receptors comprise a diverse group of proteins and polysaccharides anchored to the bacterial cell wall that mediate interactions with the host environment and other bacteria. The most prominent members are the Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs), such as the fibrinogen-binding protein SdrG (Fbe), the autolysin/adhesin AtlE, and the accumulation-associated protein (Aap). These molecules are critical for the initial attachment of the bacteria to medical devices and host tissues, as well as the subsequent formation of robust biofilms, which protect the pathogen from the host immune system and antibiotics. Additionally, the AgrC receptor serves as a key component of the quorum-sensing system, regulating virulence factor expression in response to population density. While no drugs targeting these specific receptors are currently FDA-approved, they are significant targets for the development of novel anti-infective strategies, including monoclonal antibodies and small-molecule inhibitors designed to prevent biofilm-associated infections and sepsis.

Other names
MSCRAMMsMicrobial surface components recognizing adhesive matrix moleculesAdhesinsCell wall-anchored proteinsSerine-aspartate repeat protein G (SdrG)Fibrinogen-binding protein (Fbe)Accumulation-associated protein (Aap)Autolysin/adhesin AtlEAgrC receptor
02

Mechanism of action

Inhibition of bacterial adhesion to host tissues or medical devices, disruption of biofilm formation, or interference with quorum-sensing signaling.

03

Biological functions

AdhesionBiofilm formationQuorum sensingInfectionHost-pathogen interaction
04

Disease associations

InfectionBiofilm-associated infectionSepsisEndocarditis
05

Safety considerations

Impact on commensal skin flora (S. epidermidis is a beneficial commensal)Development of bacterial resistanceLimited efficacy due to target redundancy among multiple surface proteins
06

Interacting drugs

Pagibaximab (experimental/discontinued)

3 more in the full profile.

07

Biomarkers

SdrG expression levelsAap (Accumulation-associated protein) presenceBiofilm-forming phenotypeica gene locus presence (for PIA/PNAG production)

Beyond the preview

Go deeper on Staphylococcus epidermidis cell-surface receptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcus epidermidis cell-surface receptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call